Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Office of Research and Development.

Slides:



Advertisements
Similar presentations
Perspectives from EPA’s Endocrine Disruptor Screening Program
Advertisements

Click to edit Master title style. Click to edit Master subtitle style.
Mining Association Rules from Microarray Gene Expression Data.
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
CE Introduction to Environmental Engineering and Science Readings for This Class: O hio N orthern U niversity Introduction Chemistry, Microbiology.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
Session III: Assessing Cumulative Effects of Endocrine Active Substances 9:15 - 9:30 Introduction” Rick Becker (Session Chair and Panel Moderator) 9:30.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
Office of Research and Development National Center for Computational Toxicology April 6, 2010 Exposure-Based Chemical Prioritization Workshop: Exploring.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
What Do Toxicologists Do?
Discussion Our current results suggest that it is possible to identify susceptibility regions using this methodology. The presented method takes advantage.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
TCEQ/NUATRC Air Toxics Workshop: Session V – Human Health Effects Nathan Pechacek, M.S. Toxicology Section Texas Commission on Environmental Quality
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
The Role of Research in the Business of the Environmental Protection Agency Steven Bradbury, Director Environmental Fate & Effects Division Office of Pesticide.
Committee on Carcinogenicity (COC) Approach to Risk Assessment of Genotoxic Carcinogens David H. Phillips* COC Chairman Descriptive vs. Quantitative.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Web of Causation; Exposure and Disease Outcomes Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
National Institutes of Health U.S. Department of Health and Human Services Scale, Diversity, and Complexity: Tackling Data Challenges in the Superfund.
High Throughput Genotoxicity Profiling of the US EPA ToxCast TM Chemical Library S Little 1, AW Knight 2, L Birrell 2, G Akerman 3, N McCarroll 3, D Dix.
Kevin M. Crofton, PhD US Environmental Protection Agency McKim Conference Duluth MN September 17, 2008 Thyroid Mediated CNS Dysfunction How to use what.
Click to edit Master title style Click to edit Master text styles Second level Third level Fourth level Fifth level 1 List of Nominations Perspectives.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Quantitative Assessment of Cumulative Impacts: Challenges and Progress Lauren Zeise Cal/EPA Office of Environmental Health Hazard Assessment CAPCOA Workshop:
TOXICOGENOMICS.
UNDERSTANDING CHEMICAL ALLERGEN POTENCY THROUGH THE MOLECULAR EVENTS THAT TRIGGER IMMUNE CELL ACTIVATION Elena Kummer.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Air Toxics Risk Assessment: Traditional versus New Approaches Mark Saperstein BP Product Stewardship Group.
Part 1d: Exposure Assessment and Modeling Thomas Robins, MD, MPH.
OECD’s work on Adverse outcome pathways
Introduction to Biomedical Ontology for Imaging Informatics Barry Smith, PhD, FACMI University at Buffalo May 11, 2015.
RISK DUE TO AIR POLLUTANTS
Forging Partnerships on Emerging Contaminants November 2, 2005 Elizabeth Southerland Director of Assessment & Remediation Division Office of Superfund.
McKim Conference on Predictive Toxicology The Inn of Lake Superior Duluth, Minnesota September 25-27, 2007 Toxicity Pathways as an Organizing Concept Gilman.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Title of Presentation May Go Here Department Name Presentation for March 4, 2014 University Marketing.
Office of Research and Development National Center for Environmental Assessment Human Health Risk Assessment and Information for SRP July 28, 2009 Reeder.
Key Concepts on Health Risk Assessment of Chemical Mixtures.
The Cardiovascular Disease Ontology (CVDO) Mercedes Arguello Casteleiro 1, Julie Klein 2 and Robert Stevens 1 1 School of Computer Science, University.
CDR Tarah S. Somers Commander US PHS Agency for Toxic Substances and Disease Registry May 2016 Environmental Health Nurse Agency for Toxic Substances and.
Headline sample style Intro sample style Click to edit Master text styles –Second level Third level –Fourth level o Fifth level.
National Institutes of Health U.S. Department of Health and Human Services William A. Suk, Ph.D., M.P.H. Director, Superfund Research Program Chief, Hazardous.
1 Beyond Science and Decisions: From Problem Formulation to Dose-Response - Framework.
Safe Drinking Water Act , CCL and Perchlorate
FIFRA SAP Meeting February 2, 2010
Click to Add Title Click to Add Subtitle.
Click to Add Title Click to Add Subtitle.
Decision Contexts in a Changing Toxicology Paradigm
Adverse Outcome Pathway Networks and the AOP Knowledgebase
Click to edit Master text styles
Click to Add Title Click to Add Subtitle.
Click to Add Title Click to Add Subtitle.
Author names here Author association names here
Click to edit Master text styles
TITLE SLIDE GOES HERE Optional subhead.
Click to edit Master text styles
Slide Title Edit Master text styles Second level Third level
ОПШТЕСТВО ТЕМА: МЕСТОТО ВО КОЕ ЖИВЕАМ Скопје
Author names here Author associations here
Author names here Author associations here
Using Mode of Action to Reduce Uncertainty in Risk Estimates
Click to edit Master text styles
Author names here Author associations here
Click to edit Master text styles
Introduction to Risk Assessment
Presentation transcript:

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Office of Research and Development National Center for Environmental Assessment Using High Throughput Data to Infer Adverse Outcomes (aka Designing a Semi-Automated Predictive High Throughput Toxicology Ontology-Driven Inference Engine) Lyle D. Burgoon, Ph.D. Chief, Hazardous Pollutant Assessment Group (Acting) Research Triangle Park Division National Center for Environmental Assessment Office of Research and Development United States Environmental Protection Agency The views expressed are those of the author and do not necessarily represent the views or policies of the U.S. Environmental Protection Agency.

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Challenges in Regulatory Toxicology 10,000s of chemicals in the market Many have no hazard information Many have little to no exposure information Novel data streams coming online – Quantitative structure activity relationships (QSAR) – High throughput screening assays – Toxicogenomics

Advancing the Next Generation of Risk Assessment (NexGen) PROBLEM FORMULATION Assessment Tiers Tier 1Tier 2 Tier3 Decision Context Examples Emergency response screening of chemicals of concern Identification of unregulated drinking water chemicals of concern Identification of Potential Emerging Chemical Problems or Opportunities National Air Toxics Assessment Superfund listing and removal actions Drinking Water Health Advisories National Regulatory Decisions International, State, Tribal and Local Technical Support Product- Line Prioritized List Chemicals of Concern Provisional Toxicity ValuesIRIS or ISA Minimum Data Types QSAR HT Assays Computational Toxicology Models Physical-Chemical Surrogates Limited Exposure Data Knowledge Mining & AOPs Short Duration In Vivo Exposures Automated Data Integration Extensive Exposure Data Molecular Biology Data Systems Biology Data All Policy Relevant Data Hand-Curated Data Integration Increasing Evidence

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level The REAL Challenge Data Science is the new challenge –How do we put this all together and make sense of it? Data Science Research Focus Areas: –Developing improved Quantitative Structure Activity Relationship methods/models –Combining multiple data streams to support community-based risk modeling – How to use known disease mechanisms and adverse outcome pathways to predict toxicity using high throughput screening and toxicogenomic data

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Predicting Adverse Outcomes Disease Knowledge (molecular) Chemical Mode of Action (MOA) Mode of Action Ontology (MOAO) Adverse Outcome Pathway (AOP) Knowledgebase Chemical X Predicted Adverse Outcome HTS Data stream Toxicogenomics Data stream

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Reference Ontologies The Sum Total of Describable Entities General Knowledge / Aggregators Population / Environment Organism Organ / Tissue Cell Protein / Gene Assays / References Chemicals Phenotype BFO OBI/IAO CHEBI PATO OBI / ENVO / EXO NCBI Taxonomy UBERON GO / CL GO / PRO

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Proposed Genotoxicity and Cellular Proliferation MOA

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Translating to Logic Rules Potential Outcome “Inference Rule”Confidence GenotoxicantDNA DamageHigh Confidence Genotoxicantp53 activation (sufficient to imply DNA damage) Medium Confidence GenotoxicantMDM2 AND Cdkn1a upregulation (sufficient to imply p53 activation) Low Confidence Translating to Risk Screening

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Translating to Logic Rules Potential Outcome “Inference Rule”Confidence Tumor Promoter Increase cell numbers (in vitro) High Confidence Tumor Promoter Cyclin D upregulated and CDK4 upregulated Medium Confidence Tumor Promoter Cyclin D upregulatedLow Confidence Tumor Promoter CDK4 upregulatedLow Confidence Translating to Risk Screening

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level “Theoretical” Reduction to Practice HTS AssayResult p53 transactivation assayPositive Hit MDM2 qPCR assayPositive Hit Cdkn1a qPCR assayNot Measured Salmonella mutagenicity (Ames Assay) Positive Hit Potential Genotoxicity High Confidence HTS AssayResult p53 transactivation assayPositive Hit MDM2 qPCR assayNegative Cdkn1a qPCR assayNegative Salmonella mutagenicity (Ames Assay) Equivocal Potential Genotoxicity Medium Confidence

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Reduction to Practice GeneUpregulation / Downregulation Confidence p53Not measuredMedium MDM2UpregulatedLow Cdkn1aUpregulatedLow Potential Genotoxicity (Inferred) Low Confidence* Benzo[a]Pyrene Toxicogenomics Example Applying the Ontology Logic Rules English: MDM2 and Cdkn1a upregulation infers p53 is activated * No data confidence statement is made here; however, we envision a data confidence statement will be made in the future

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Evidence Map for Genotoxicity Pro-Arguments (2 genes): MDM2 upregulated (2 studies) 1 time course 1 dose-response Cdkn1a upregulated (2 studies) 1 time course 1 dose-response MDM2 + Cdkn1a upregulation infers p53 activation p53 activation infers DNA damage Attenuating Information: 2 microarray studies are better than 1, but still provide weak evidence Microarray studies do not provide direct evidence of DNA damage Scorecard: 2 low confidence 1 medium confidence (inferred) 2 microarray studies (medium confidence total) Potential (Inferred) Genotoxicity Low Confidence (Inference)* * Can increase confidence when considering other information from the same studies: DNA adduct measurements p53 direct assays

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Bottom-line Ontology-based inference will provide a quick, automated way to predict adverse outcomes Predictions are appropriate for: –Hypothesis generation –Screening and prioritization –Risk assessment when combined with complementary existing data Confidence statements –Initially humans should provide these –Future: computers estimate using decision rules with humans making final call?

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level MOA Ontology and AOP Knowledgebase Team Kyle Painter (ORISE; EPA/ORD/NCEA) Stephen Edwards (EPA/ORD/NHEERL) David Lyons (EPA/ORD/OSIM) Ryan Durden (EPA/ORD/NHEERL)

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level EXTRA SLIDES

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Thoughts on Microarray Data Microarray data are generally of low-medium confidence – Individual microarray studies Large amount of variance Low statistical power Low confidence –Meta-analyses Combine multiple studies together (3 examples) –Combine groups across multiple studies into single analysis –Pre-process the same way; followed by consistency of pathway- based results –Consistency of pathway-based results (possibly pre-processed in different ways) Medium confidence –If results are consistent across multiple studies –If several combined into single analysis, may still be low confidence depending upon study quality

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Reference Ontologies

Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Reference Ontologies The Sum Total of Describable Entities General Knowledge / Aggregators Population / Environment Organism Organ / Tissue Cell Protein / Gene Assays / References Chemicals Phenotype BFO OBI/IAO CHEBI PATO OBI / ENVO / EXO NCBI Taxonomy UBERON GO / CL GO / PRO